| | Vertex Moves Ahead with Phase 3 Trials ofOnce-Daily Triple Combination Therapy
| |
| CDC Updates Mask Guidance
| |
The CDC has recommended that all people wear masks indoors in areas where COVID-19 is spreading quickly — regardless of their vaccination status, and that those with a weakened immune system or underlying medical condition might choose to wear a mask regardless of level of transmission in their area. The updated guidance is based on an increase in the number of cases among fully vaccinated people. Research has shown that fully vaccinated people can be infected and infect others.
Learn more in our COVID-19 Community Q&A »
| |
| CF Community Advocates for CF Program Funding
| |
Many states have wrapped up their annual budget process for Fiscal Year 2022. This year, the Foundation remained focused on protecting against cuts to state programs that support both adults and children living with CF. Community members weighed in to ensure that lawmakers across the country understand the importance of these programs, and as a result of our efforts, CF programs in numerous states including New York and Pennsylvania received full or increased funding.
Sign up for advocacy alerts for more opportunities to advocate »
| |
| Register for our Sinus Disease Research Webinar
| |
Join us Wednesday, August 25 at 7 p.m. ET to learn about the latest research addressing this important topic, including studies looking at the impact of highly effective modulators on sinus disease and sinus surgery outcomes. Plus, have an opportunity to ask your sinus research-related questions to CF researchers Daniel Beswick, MD, from UCLA, and Anna Zemke, PhD, from the University of Pittsburgh, during an audience Q&A. Unable to watch live? All those who register will receive a link to the recording after the event.
| |
|
|
|
|
